The role of the androgen receptor in ovarian cancer carcinogenesis and its clinical implications

Haiyan Zhu, Xuejie Zhu, Lihong Zheng, Xiaoli Hu, Lu Zhe Sun, Xueqiong Zhu

Research output: Contribution to journalReview articlepeer-review

12 Scopus citations

Abstract

Ovarian cancer is the major cause of death in women with gynecologic malignancies. There is emerging evidence that Androgen/androgen receptor (AR) signaling plays a critical role in the etiology and progression of this disease. Androgen receptor is frequently expressed in various subtypes of ovarian cancers and androgen/ AR signaling has been shown to promote proliferation, migration, and invasion of ovarian cancer cells. Furthermore, shorter AR CAG repeats length and increased AR activity are associated with increased ovarian cancer risk and may be a useful prognosticator under certain circumstances. Here, we summarize current findings regarding the role of the AR in ovarian cancer and discuss agents that target this pathway as potential therapeutics for ovarian cancer.

Original languageEnglish (US)
Pages (from-to)29395-29405
Number of pages11
JournalOncotarget
Volume8
Issue number17
DOIs
StatePublished - 2017

Keywords

  • Androgen receptor
  • Clinical implications
  • Ovarian cancer

ASJC Scopus subject areas

  • Oncology

Fingerprint Dive into the research topics of 'The role of the androgen receptor in ovarian cancer carcinogenesis and its clinical implications'. Together they form a unique fingerprint.

Cite this